Atlas Trials

Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in Glioma

Clinical trial NCT06885333 · COMPLETED

Trial details

NCT number
NCT06885333
Sponsor
West China Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
GliomaGlioma : Oligodendroglioma or Astrocytoma
Start date
2016-05-01
Primary completion
2024-09-01
Enrollment
192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.